Skip to Main content Skip to Navigation
Journal articles

Of chloroquine and COVID-19

Franck Touret 1, * Xavier de Lamballerie 1, * 
* Corresponding author
Abstract : Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2). The scientific community should consider this information in light of previous experiments with chloroquine in the field of antiviral research.
Complete list of metadata

https://www.hal.inserm.fr/inserm-02519612
Contributor : Accord Elsevier CCSD Connect in order to contact the contributor
Submitted on : Monday, August 22, 2022 - 8:33:42 AM
Last modification on : Tuesday, August 23, 2022 - 3:03:36 AM

File

S0166354220301145.pdf
Files produced by the author(s)

Licence


Distributed under a Creative Commons Attribution - NonCommercial 4.0 International License

Identifiers

Collections

Citation

Franck Touret, Xavier de Lamballerie. Of chloroquine and COVID-19. Antiviral Research, Elsevier Masson, 2020, 177, pp.104762. ⟨10.1016/j.antiviral.2020.104762⟩. ⟨inserm-02519612⟩

Share

Metrics

Record views

646

Files downloads

4